For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

MOH and HSA are reviewing the advertisements on weight-loss drugs flagged by ST. Read more at straitstimes.com.

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...

The emergence and development of glucagon-like Peptide-1 agonists (GLP-1s) is the primary trend of interest in the ...

ST signed up with 7 telehealth platforms in July to check how easy it would be to get weight-loss drugs. Read more at ...

ST has seen telehealth operators promoting their weight-loss programmes, along with glucagon-like peptide-1 (GLP-1) drugs, on ...

Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...

The global Oral Anti-Diabetic Drug market is poised for substantial growth, driven by increasing diabetes cases, advancements ...

Insurers, including the state, might consider serving up exercise and cooking classes along with the prescription.